Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114831) titled 'A Single-Arm, Multicenter Clinical Study of Liotinib Combined with Chemotherapy in the Treatment of Advanced EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer Resistant to EGFR-TKI Therapy' on Dec. 17, 2025.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Qilu Hospital of Shandong University

Condition: Advanced EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-01-01

Target Sample Size: Experimental group:61;

Countries of Recruitment: China

To know more, visit https://www.chictr.or...